Finanzas de National Healthcare Corp (NHC)NHCNational Healthcare Corp

National Healthcare Corp (NHC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Net Patient Revenues, accounting for 92.7% of total sales, equivalent to $378.36M. Another important revenue stream is Other revenues. Understanding this composition is critical for investors evaluating how NHC navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, National Healthcare Corp maintains a gross margin of 36.73%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.28%, while the net margin is 9.93%. These profitability ratios, combined with a Return on Equity (ROE) of 13.08%, provide a clear picture of how effectively NHC converts its operational activities into shareholder value.

In the context of the broader market, NHC competes directly with industry leaders such as BKD and SGRY. With a market capitalization of $3.56B, it holds a leading position in the sector. When comparing efficiency, NHC's gross margin of 36.73% stands against BKD's 18.74% and SGRY's 17.78%. Such benchmarking helps identify whether National Healthcare Corp is trading at a premium or discount relative to its financial performance.

National Healthcare Corp has shown consistent revenue growth, with Q2 2026 revenue at $408.02 million, an 8.8% increase year-over-year. The net income for the same quarter was $40.32 million, significantly up from $23.72 million a year prior, indicating strong profitability improvement.